1. Home
  2. SLGL vs SFHG Comparison

SLGL vs SFHG Comparison

Compare SLGL & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • SFHG
  • Stock Information
  • Founded
  • SLGL 1997
  • SFHG 1993
  • Country
  • SLGL Israel
  • SFHG Hong Kong
  • Employees
  • SLGL N/A
  • SFHG 216
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • SLGL Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • SLGL 21.1M
  • SFHG 16.2M
  • IPO Year
  • SLGL 2018
  • SFHG 2024
  • Fundamental
  • Price
  • SLGL $7.24
  • SFHG $0.80
  • Analyst Decision
  • SLGL Buy
  • SFHG
  • Analyst Count
  • SLGL 1
  • SFHG 0
  • Target Price
  • SLGL $40.00
  • SFHG N/A
  • AVG Volume (30 Days)
  • SLGL 13.2K
  • SFHG 87.2K
  • Earning Date
  • SLGL 05-23-2025
  • SFHG 06-21-2025
  • Dividend Yield
  • SLGL N/A
  • SFHG N/A
  • EPS Growth
  • SLGL N/A
  • SFHG N/A
  • EPS
  • SLGL N/A
  • SFHG N/A
  • Revenue
  • SLGL $12,103,000.00
  • SFHG $19,760,935.00
  • Revenue This Year
  • SLGL N/A
  • SFHG N/A
  • Revenue Next Year
  • SLGL $31.17
  • SFHG N/A
  • P/E Ratio
  • SLGL N/A
  • SFHG N/A
  • Revenue Growth
  • SLGL 603.66
  • SFHG 30.89
  • 52 Week Low
  • SLGL $3.34
  • SFHG $0.55
  • 52 Week High
  • SLGL $16.50
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 50.26
  • SFHG N/A
  • Support Level
  • SLGL $7.15
  • SFHG N/A
  • Resistance Level
  • SLGL $7.45
  • SFHG N/A
  • Average True Range (ATR)
  • SLGL 0.32
  • SFHG 0.00
  • MACD
  • SLGL -0.10
  • SFHG 0.00
  • Stochastic Oscillator
  • SLGL 31.36
  • SFHG 0.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: